The stock of Immutep Limited ADR (IMMP) has gone down by -10.04% for the week, with a -5.02% drop in the past month and a 8.72% rise in the past quarter. The volatility ratio for the week is 7.85%, and the volatility levels for the past 30 days are 6.65% for IMMP. The simple moving average for the last 20 days is -13.33% for IMMP’s stock, with a simple moving average of 13.57% for the last 200 days.
Is It Worth Investing in Immutep Limited ADR (NASDAQ: IMMP) Right Now?
IMMP has 36-month beta value of 2.26. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for IMMP is 115.40M, and currently, short sellers hold a 3.23% ratio of that float. The average trading volume of IMMP on June 05, 2024 was 236.57K shares.
IMMP) stock’s latest price update
The stock price of Immutep Limited ADR (NASDAQ: IMMP) has dropped by -14.26 compared to previous close of 2.98. Despite this, the company has seen a fall of -10.04% in its stock price over the last five trading days. globenewswire.com reported 2024-06-05 that Sydney, Australia, June 05, 2024 (GLOBE NEWSWIRE) — Immutep Limited ACN 009 237 889 (ASX: IMM, NASDAQ: IMMP) (Immutep or the Company) is pleased to announce the successful completion of its institutional placement (Placement) and the institutional component (Institutional Entitlement Offer) of its 1 for 16 pro rata accelerated non-renounceable entitlement offer (Entitlement Offer and, together with the Placement, the Offer) of new fully paid ordinary shares in Immutep (New Shares).
Analysts’ Opinion of IMMP
Many brokerage firms have already submitted their reports for IMMP stocks, with CapitalOne repeating the rating for IMMP by listing it as a “Overweight.” The predicted price for IMMP in the upcoming period, according to CapitalOne is $10 based on the research report published on May 17, 2024 of the current year 2024.
Robert W. Baird, on the other hand, stated in their research note that they expect to see IMMP reach a price target of $7. The rating they have provided for IMMP stocks is “Outperform” according to the report published on August 03rd, 2023.
Ladenburg Thalmann gave a rating of “Buy” to IMMP, setting the target price at $8.30 in the report published on August 03rd of the previous year.
IMMP Trading at -4.82% from the 50-Day Moving Average
After a stumble in the market that brought IMMP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -23.39% of loss for the given period.
Volatility was left at 6.65%, however, over the last 30 days, the volatility rate increased by 7.85%, as shares sank -10.28% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +0.80% upper at present.
During the last 5 trading sessions, IMMP fell by -10.92%, which changed the moving average for the period of 200-days by +29.08% in comparison to the 20-day moving average, which settled at $2.93. In addition, Immutep Limited ADR saw 6.46% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for IMMP
Current profitability levels for the company are sitting at:
- -12.49 for the present operating margin
- 0.49 for the gross margin
The net margin for Immutep Limited ADR stands at -10.88. The total capital return value is set at -0.6. Equity return is now at value -41.05, with -37.64 for asset returns.
Based on Immutep Limited ADR (IMMP), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -24.09. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is -2250.16.
Currently, EBITDA for the company is -42.88 million with net debt to EBITDA at 1.52. When we switch over and look at the enterprise to sales, we see a ratio of 63.13. The receivables turnover for the company is 0.91for trailing twelve months and the total asset turnover is 0.05. The liquidity ratio also appears to be rather interesting for investors as it stands at 17.24.
Conclusion
To put it simply, Immutep Limited ADR (IMMP) has had a mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
